Modalities
Labcorp’s biopharmaceutical CMC services offer a wide breadth of service lines and support of multiple modalities.
Monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs) and bispecific antibodies (BsAbs)
Recombinant proteins and peptide therapeutics
Subunit and mRNA lipid nanoparticles (LNPs) vaccine formulation, pre-formulation, adjuvant and delivery optimization
Cell and gene therapies as well as engineered bacteria therapies